These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2659162

  • 1. Effect in vivo of multiple injections of purified murine and recombinant human macrophage colony-stimulating factor to mice.
    Chikkappa G, Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Greenberg ML, Waheed A, Shadduck RK.
    Cancer Res; 1989 Jul 01; 49(13):3558-61. PubMed ID: 2659162
    [Abstract] [Full Text] [Related]

  • 2. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Jul 01; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice.
    Broxmeyer HE, Williams DE, Cooper S, Hangoc G, Ralph P.
    J Cell Biochem; 1988 Oct 01; 38(2):127-36. PubMed ID: 2464604
    [Abstract] [Full Text] [Related]

  • 4. Influence of purified recombinant human macrophage colony stimulating factor in mice.
    Broxmeyer HE, Geissler K, Cooper S, Williams DE.
    Biotechnol Ther; 1988 Oct 01; 1(1):43-54. PubMed ID: 2562643
    [Abstract] [Full Text] [Related]

  • 5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 6. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr 01; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 7. Effects of long-term in vivo treatment of mice with purified murine recombinant GM-CSF.
    Pojda Z, Molineux G, Dexter TM.
    Exp Hematol; 1989 Dec 01; 17(11):1100-4. PubMed ID: 2684679
    [Abstract] [Full Text] [Related]

  • 8. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS, Shedlofsky SI, Swim AT, Robinson JM, Hulette BC, Messino MJ, Doukas MA.
    J Biol Response Mod; 1989 Aug 01; 8(4):422-39. PubMed ID: 2666587
    [Abstract] [Full Text] [Related]

  • 9. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug 01; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 10. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1994 Jan 01; 22(1):100-2. PubMed ID: 7506671
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effects of granulocyte-colony stimulating factor and macrophage-colony stimulating factor on recovery of donor hematopoietic cells in allogeneic bone marrow transplantation.
    Zhang Y, Adachi Y, Suzuki Y, Minamino K, Iwasaki M, Nakano K, Koike Y, Mukaide H, Shigematsu A, Kiriyama N, Li C, Ikehara S.
    Oncol Rep; 2006 Aug 01; 16(2):367-71. PubMed ID: 16820917
    [Abstract] [Full Text] [Related]

  • 12. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells.
    Metcalf D, Nicola NA.
    J Cell Physiol; 1983 Aug 01; 116(2):198-206. PubMed ID: 6602806
    [Abstract] [Full Text] [Related]

  • 13. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha.
    Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE.
    J Immunol; 1992 Aug 01; 149(3):1004-9. PubMed ID: 1634758
    [Abstract] [Full Text] [Related]

  • 14. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G, Bueren JA, Maganto G, Tuduri P, Guerrero A, Pivel JP, Real A.
    Stem Cells; 1995 Mar 01; 13(2):175-85. PubMed ID: 7540471
    [Abstract] [Full Text] [Related]

  • 15. Histamine-producing cell-stimulating activity. Interleukin 3 and granulocyte-macrophage colony-stimulating factor induce de novo synthesis of histidine decarboxylase in hemopoietic progenitor cells.
    Schneider E, Pollard H, Lepault F, Guy-Grand D, Minkowski M, Dy M.
    J Immunol; 1987 Dec 01; 139(11):3710-7. PubMed ID: 2824613
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
    Schuening FG, Storb R, Goehle S, Nash R, Graham TC, Appelbaum FR, Hackman R, Sandmaier BM, Urdal DL.
    Exp Hematol; 1989 Sep 01; 17(8):889-94. PubMed ID: 2670596
    [Abstract] [Full Text] [Related]

  • 17. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N, Chertkov J, Samoilina N, Zander A.
    Exp Hematol; 1996 Jun 01; 24(7):816-22. PubMed ID: 8647232
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
    Wu DD, Nayar R, Keating A.
    Exp Hematol; 1994 Jun 01; 22(6):495-500. PubMed ID: 7514543
    [Abstract] [Full Text] [Related]

  • 19. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 01; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 20. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar 01; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.